Antithrombin Alfa
- Generic Name
- Antithrombin Alfa
- Brand Names
- Atryn
- Drug Type
- Biotech
- CAS Number
- 84720-88-7
- Unique Ingredient Identifier
- AWV6I5L6H2
- Background
Antithrombin Alfa is a recombinant antithrombin , an anticoagulant, that is used for the prevention of thromboembolic events in patients that have hereditary deficiency of antithrombin in high risk situations.
- Indication
Antithrombin alfa is a recombinant antithrombin it is indicated for the prevention of peri-operative and peri-partum thromboembolic events in patients with hereditary deficiency of antithrombin.
- Associated Conditions
- Postoperative Thromboembolism, Postpartum thrombosis
Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients
Early Phase 1
Withdrawn
- Conditions
- Antithrombin Deficiency Type 2
- Interventions
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT03090893
Understanding "Heparin Resistance" in Cardiac Surgery
Phase 1
Completed
- Conditions
- Cardiopulmonary BypassAltered Heparin Response
- Interventions
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 504
- Registration Number
- NCT01598883
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates
Phase 1
Terminated
- Conditions
- Postoperative Hemorrhage
- Interventions
- Other: Placebo
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2014-01-20
- Lead Sponsor
- Medical College of Wisconsin
- Target Recruit Count
- 8
- Registration Number
- NCT01158729
- Locations
- 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath